로딩 중…
지수 로딩 중…
Rigel Pharmaceuticals, Inc.
RIGL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$32.91-1.38%
2026-06-18
Price Chart
Rigel Pharmaceuticals, Inc.+69.99%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $609M |
| Revenue | $300M |
| Net Income | $364M |
| Total Assets | $505M |
| Net Assets | $400M |
| Value | |
| P/E | 1.67x |
| P/B | 1.52x |
| P/S | 2.03x |
| EV/EBITDA | 4.80x |
| FCF Yield | 13.02% |
| Profitability | |
| ROE | 91.08% |
| ROA | 72.18% |
| Op. Margin | 41.56% |
| Revenue Growth | 10.28% |
| Earnings Growth | -24.39% |
| Financial Health | |
| Debt Ratio | 26.18% |
| Total Debt | $46M |
| FCF | $79M |
| Cash | $24M |
| Current Ratio | 2.62x |
| Net Debt/EBITDA | 0.16x |
| Performance | |
| 1Y Return | 69.99% |
| 1M Return | 16.29% |
| From 52W High | -37.00% |
| 1Y MDD | -50.08% |
| Trading | |
| Volume | 559,252 shares |
| Trading Value | $19M |
| Per Share | |
| EPS | $20.40 |
| BPS | $21.76 |